Nuclear Medicine and Biology
Volume 35, Issue 2 , Pages 151-158 , February 2008

Biodistribution and tumor imaging of an anti-CEA single-chain antibody–albumin fusion protein

  • Paul J. Yazaki

      Affiliations

    • Division of Cancer Immunotherapeutics and Tumor Immunology, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 626 256 4673; fax: +1 626 301 8280.
    • ,
  • Thewodros Kassa

      Affiliations

    • Division of Cancer Immunotherapeutics and Tumor Immunology, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA
    • ,
  • Chia-wei Cheung

      Affiliations

    • Division of Cancer Immunotherapeutics and Tumor Immunology, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA
    • ,
  • Desiree M. Crow

      Affiliations

    • Division of Cancer Immunotherapeutics and Tumor Immunology, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA
    • ,
  • Mark A. Sherman

      Affiliations

    • Division of Information Sciences, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA
    • ,
  • James R. Bading

      Affiliations

    • Division of Cancer Immunotherapeutics and Tumor Immunology, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA
    • ,
  • Anne-Line J. Anderson

      Affiliations

    • Division of Cancer Immunotherapeutics and Tumor Immunology, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA
    • ,
  • David Colcher

      Affiliations

    • Division of Cancer Immunotherapeutics and Tumor Immunology, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA
    • ,
  • Andrew Raubitschek

      Affiliations

    • Division of Cancer Immunotherapeutics and Tumor Immunology, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA

Received 15 August 2007 ,Revised 19 October 2007 ,Accepted 24 October 2007.

References 

  1. Chuang VT, Kragh-Hansen U, Otagiri M. Pharmaceutical strategies utilizing recombinant human serum albumin. Pharm Res. 2002;19:569–577
  2. Smith BJ, Popplewell A, Athwal D, Chapman AP, Heywood S, West SM, et al. Prolonged in vivo residence times of antibody fragments associated with albumin. Bioconjug Chem. 2001;12:750–756
  3. Huhalov A, Chester KA. Engineered single chain antibody fragments for radioimmunotherapy. Q J Nucl Med Mol Imaging. 2004;48:279–288
  4. Dennis MS, Zhang M, Meng YG, Kadkhodayan M, Kirchhofer D, Combs D, et al. Albumin binding as a general strategy for improving the pharmacokinetics of proteins. J Biol Chem. 2002;277:35035–35043
  5. Dennis MS, Jin H, Dugger D, Yang R, McFarland L, Ogasawara A, et al. Imaging tumors with an albumin-binding Fab, a novel tumor-targeting agent. Cancer Res. 2007;67:254–261
  6. Orlova A, Tolmachev V, Pehrson R, Lindborg M, Tran T, Sandstrom M, et al. Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors. Cancer Res. 2007;67:2178–2186
  7. Wu AM, Yazaki PJ. Designer genes: recombinant antibody fragments for biological imaging. Q J Nucl Med. 2000;44:268–283
  8. Wu AM, Chen W, Raubitschek A, Williams LE, Neumaier M, Fischer R, et al. Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers. Immunotechnology. 1996;2:21–36
  9. Wong JY, Chu DZ, Williams LE, Yamauchi DM, Ikle DN, Kwok CS, et al. Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer. Clin Cancer Res. 2004;15:5014–5021
  10. Yazaki PJ, Wu AM, Tsai S-W, Williams L, Ikle DN, Wong JYC, et al. Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and T84.66 minibody: Comparison to radioiodinated fragments. Bioconj Chem. 2001;12:220–228
  11. Peter T. All about albumin: biochemistry, genetics and medical applications. San Diego (CA): Academic Press; 1996;
  12. Anderson CL, Chaudhury C, Kim J, Bronson CL, Wani MA, Mohanty S. Perspective — FcRn transports albumin: relevance to immunology and medicine. Trends Immunol. 2006;27:343–348
  13. Wu AM. Engineering multivalent antibody fragments for in vivo targeting. Methods Mol Biol. 2004;248:209–225
  14. Carmichael JA, Power BE, Garrett TP, Yazaki PJ, Shively JE, Raubitschek AA, et al. The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs in V(L)-to-V(H) orientation: implications for diabody flexibility. J Mol Biol. 2003;326:341–351
  15. Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K. Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng. 1999;12:439–446
  16. Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene. 1989;77:61–68
  17. Yazaki PJ, Wu AM. Expression of recombinant antibodies in mammalian cell lines. Methods Mol Biol. 2004;248:255–268
  18. Qi J, Leahy RM. Resolution and noise properties of MAP reconstruction for fully 3-D PET. IEEE Trans Med Imaging. 2000;19:493–506
  19. Adams GP, Schier R, McCall AM, Simmons HH, Horak EM, Alpaugh RK, et al. High affinity restricts the localization and tumor penetration of single-chain Fv antibody molecules. Cancer Res. 2001;61:4750–4755
  20. Tanaka T, Shiramoto S, Miyashita M, Fujishima Y, Kaneo Y. Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME). Int J Pharm. 2004;277:39–61
  21. Wang J, Ueno H, Masuko T, Hashimoto Y. Binding of serum albumin on tumor cells and characterization of the albumin binding protein. J Biochem (Tokyo). 1994;115:898–903
  22. Wu AM, Williams LE, Zieran L, Padma A, Sherman MA, Bebb GG, et al. Anti-carcinoembryonic antigen (CEA) diabody for rapid tumor targeting and imaging. Tumor Targeting. 1999;4:47–58
  23. Yazaki PJ, Sherman MA, Shively JE, Ikle D, Williams LE, Wong JYC, et al. Humanization of the anti-CEA T84.66 antibody based on crystal structure data. Protein Eng Des Sel. 2004;17:481–489

☆ This research was supported by NCI grant 43904.

PII: S0969-8051(07)00273-9

doi: 10.1016/j.nucmedbio.2007.10.010

Nuclear Medicine and Biology
Volume 35, Issue 2 , Pages 151-158 , February 2008

Article Tools

* Image Usage & Resolution